ePrints

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia

Lookup NU author(s): Dr Britta Vormoor, Professor Gareth Veal, Melanie Griffin, Professor Julie Irving, Lynne Minto, Marian Case, Claire Schwab, Professor Christine Harrison FRCPath FMedSci, Professor Hermann Josef Vormoor

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Vormoor B, Veal GJ, Griffin MJ, Boddy AV, Irving J, Minto L, Case M, Banerji U, Swales KE, Tall JR, Moore AS, Toguchi M, Acton G, Dyer K, Schwab C, Harrison CJ, Grainger JD, Lancaster D, Kearns P, Hargrave D, Vormoor J

Publication type: Article

Publication status: Published

Journal: Pediatric Blood & Cancer

Year: 2017

Volume: 64

Issue: 6

Pages: e26351 1-4

Print publication date: 01/06/2017

Online publication date: 01/12/2016

Acceptance date: 07/10/2016

ISSN (print): 1545-5009

ISSN (electronic): 1545-5017

Publisher: John Wiley & Sons, Inc.

URL: https://doi.org/10.1002/pbc.26351

DOI: 10.1002/pbc.26351

Altmetrics

Share